FDA Announces No Child Under 18 Should Take Cough Syrup With Codeine ~ health and fitness,celebrity news,fashion blog,beauty women,whole foods,quotes about love

vendredi 21 avril 2017

FDA Announces No Child Under 18 Should Take Cough Syrup With Codeine

The FDA announced on April 20 an update to two previous safety warnings from July and September 2015 informing against the use of prescription medications containing codeine for children under the age of 12, expanding the age restriction to 18 and under. Codeine and tramadol, both found in some cough medicines and pain relievers, are opioids, a type of narcotic that could cause dangerously slowed breathing in some children, which could lead to death.

These medications were found to have particularly adverse effects in kids ages 12 to 18 who are obese or may have conditions such as obstructive sleep apnea or severe lung disease, as they further increase the risk of breathing difficulties. However, the FDA warns against the use of these medications in any child, especially under the age of 12.

"This is something we've been watching for several years," Douglas Throckmorton, the deputy director for regulatory programs at the FDA's Center for Drug Evaluation and Research, told NPR. "They are powerful, effective medicines when used right [but] they can cause a lot of harm when they're not."

"My concern, were I to be prescribing codeine in children, would be that I would, frankly, kill them," added Maria Pruchnicki, a pharmacist and associate professor at the Ohio State University College of Pharmacy.

Although the new warning didn't extend to include over-the-counter medications such as cough syrups, the FDA is considering adding regulations on the labels of these products and recommends that parents talk to a doctor before giving their children these medications. The FDA is also requiring that these prescription drugs have warnings on the label for breastfeeding mothers, as they found "numerous cases of excess sleepiness and serious breathing problems in breastfed infants, including one death" while conducting research.

While they continue looking into safety issues associated with these drugs, the FDA urges caregivers to check medication labels before giving children medication and asks both parents and healthcare professionals to report adverse symptoms and side effects of codeine or tramadol - such as slow or shallow breathing, difficulty or noisy breathing, confusion, excess fatigue, trouble breastfeeding, or limpness - directly to them.

vendredi 21 avril 2017